Regeneron Pharmaceuticals | هزینه بهره بدهی



Interest Expense On Debt تغییر دادن تاریخ
AbbVie USD 610M 19M 2024-12
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amgen USD 723M 24M 2025-03
Astellas Pharma 3.91B 320M 2025-03
AstraZeneca 429M 28M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
J&J USD 128M 9M 2025-03
Kyowa Hakko Kirin 5.64B 4.66B 2024-12
Merck USD 313M 15M 2025-03
Moderna USD 1000K 5M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 66.11M 20.67M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Teva Pharmaceutical Industries USD 224M 1000K 2024-12
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
United Therapeutics USD 6.1M 1.8M 2025-03
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



Regeneron Pharmaceuticals هزینه بهره بدهی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - May 2025.